Will high-margin acquisitions in Q3 soften the squeeze on future earnings? BNN speaks with Douglas Loe, healthcare and biotech analyst, Versant Partners.
Expansion into the U.S. squeezed CML's margins in Q3. Will the company keep looking to the U.S. for growth in Q4? BNN speaks with Paul Bristow, president and CEO, CML Healthcare Income Fund.